We are live on
!
Find out more
B
Baird Portfolio holdings
AUM
$9.78B
1-Year Est. Return
11.39%
This Fund
S&P 500
This Quarter
Est. Return
+5.29%
1 Year Est. Return
+11.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.4B
AUM Growth
+$2.27B
(+32%)
Cap. Flow
+$1.96B
Cap. Flow
% of AUM
20.91%
Top 10 Holdings %
Top 10 Hldgs %
12.31%
Holding
1,361
New
265
Increased
661
Reduced
307
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$78.3M |
| 2 |
HSP
HOSPIRA INC
HSP
|
+$41.9M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$38.7M |
| 4 |
Digital Realty Trust
DLR
|
+$38.2M |
| 5 |
Sanofi
SNY
|
+$37.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Skyworks Solutions
SWKS
|
+$32M |
| 2 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$31.8M |
| 3 |
ManpowerGroup
MAN
|
+$31.5M |
| 4 |
Microchip Technology
MCHP
|
+$30M |
| 5 |
IBM
IBM
|
+$28.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.33% |
| 2 | Industrials | 12.32% |
| 3 | Healthcare | 11.51% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Financials | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Zumiez
ZUMZ
$315M
| $7.87M | 0.08% |
+203,743
| New | +$6.96M |
|
252
Regeneron Pharmaceuticals
REGN
$68.3B
| $7.84M | 0.08% |
19,121
-143
| -0.7% | -$56.2K |
|
253
Ryder
R
$10.4B
| $7.83M | 0.08% |
84,268
+32,837
| +64% | +$2.93M |
|
254
Devon Energy
DVN
$52.5B
| $7.73M | 0.08% |
126,329
+49,065
| +64% | +$2.97M |
|
255
Aflac
AFL
$62.9B
| $7.64M | 0.08% |
250,228
+21,720
| +10% | +$641K |
|
256
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.37B
| $7.59M | 0.08% |
143,735
-2,692
| -2% | -$138K |
|
257
First Trust Health Care AlphaDEX Fund
FXH
$1.01B
| $7.59M | 0.08% |
125,952
+4,920
| +4% | +$287K |
|
258
Vanguard Growth ETF
VUG
$217B
| $7.44M | 0.08% |
427,734
+3,132
| +0.7% | +$53.2K |
|
259
Caterpillar
CAT
$417B
| $7.38M | 0.08% |
80,640
+6,462
| +9% | +$629K |
|
260
Rayonier
RYN
$6.38B
| $7.34M | 0.08% |
+289,400
| New | +$7.76M |
|
261
Invesco S&P 500 Equal Weight ETF
RSP
$95.3B
| $7.3M | 0.08% |
91,251
+8,361
| +10% | +$650K |
|
262
Novartis
NVS
$297B
| $7.29M | 0.08% |
87,864
-6,697
| -7% | -$555K |
|
263
Paychex
PAYX
$39.1B
| $7.26M | 0.08% |
157,276
-9,930
| -6% | -$459K |
|
264
Motorcar Parts of America
MPAA
$255M
| $7.25M | 0.08% |
233,107
+3,843
| +2% | +$116K |
|
265
Invesco Dorsey Wright Momentum ETF
PDP
$1.53B
| $7.25M | 0.08% |
176,480
+9,698
| +6% | +$389K |
|
266
J.M. Smucker
SJM
$12.4B
| $7.25M | 0.08% |
71,751
+65,635
| +1,073% | +$6.65M |
|
267
Stryker
SYK
$121B
| $7.21M | 0.08% |
76,445
+10,850
| +17% | +$962K |
|
268
iShares Russell Mid-Cap Value ETF
IWS
$15.5B
| $7.12M | 0.08% |
96,574
-2,771
| -3% | -$199K |
|
269
Eli Lilly
LLY
$1.06T
| $7.11M | 0.08% |
103,054
+32,270
| +46% | +$2.18M |
|
270
C.H. Robinson
CHRW
$24.3B
| $7.02M | 0.07% |
93,792
+86,072
| +1,115% | +$6.14M |
|
|
SABA
271
Saba Capital Income & Opportunities Fund II
SABA
$222M
| $7.01M | 0.07% |
487,729
-109,951
| -18% | -$1.68M |
|
272
Exelon
EXC
$48.1B
| $6.96M | 0.07% |
263,073
+192,346
| +272% | +$4.94M |
|
273
NXP Semiconductors
NXPI
$69.3B
| $6.94M | 0.07% |
90,821
+13,024
| +17% | +$923K |
|
274
Becton Dickinson
BDX
$42.1B
| $6.84M | 0.07% |
50,355
+28,217
| +127% | +$3.61M |
|
275
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.36B
| $6.82M | 0.07% |
156,090
+47,209
| +43% | +$2.02M |
|
Similar funds
JCMLC
CIFMU
BPBT
RVP
ICM
FAAM
SAG
GIM
Baird's Q4 2014 Portfolio in Review
As of Q4 2014, Baird held 1,361 positions worth $9.4B, up 32% from $7.12B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Baird deployed $1.96B of net new capital in Q4 2014, opening 265 new positions and adding to 661 existing holdings. Its largest new stake was HOSPIRA INC: 742,689 shares worth $45.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Skyworks Solutions, an estimated $32M trimmed.
- Baird's largest Q4 2014 buy was HOSPIRA INC: 742,689 shares worth $45.5M.
- Baird added most to Microsoft in Q4 2014, an estimated $78.3M increase.
- Baird's biggest Q4 2014 reduction was Skyworks Solutions, cutting an estimated $32M.
- Baird fully exited SALIX PHARMACEUTICALS LTD DEL in Q4 2014, selling an estimated $31.8M.
- Baird's ten largest holdings make up 12% of its $9.4B portfolio in Q4 2014.
- Baird opened 265 new positions and closed 94 in Q4 2014.
- Baird's portfolio value rose 32% quarter-over-quarter to $9.4B.
Based on Baird's 13F filing for Q4 2014, filed 12 Feb 2015.